Tscan Therapeutics Inc - TCRX - stock price prediction, stock price target, analyst ratings from 6 analysts

Tscan Therapeutics Inc has a share price target of US$ 6, revenue growth forecast of -18.0%, and profit growth estimate of 22.7% for FY26, based on top 6 analyst calls.